1998
DOI: 10.1161/01.cir.97.23.2331
|View full text |Cite
|
Sign up to set email alerts
|

Tachycardia-Induced Change of Atrial Refractory Period in Humans

Abstract: Background-Atrial fibrillation (AF) has been shown to shorten the atrial effective refractory period (ERP) and make the atrium more vulnerable to AF. This study investigated the effect of atrial rate and antiarrhythmic drugs on ERP shortening induced by tachycardia. Methods and Results-Seventy adult patients without structural heart disease were included. For the first part of the study, right atrial ERP was measured with a drive cycle length of 500 ms before and after 10 minutes of rapid atrial pacing using f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
62
1
10

Year Published

2001
2001
2010
2010

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 141 publications
(77 citation statements)
references
References 43 publications
4
62
1
10
Order By: Relevance
“…Shortening of the atrial ERP has been reported as one of the main underlying electrophysiological changes in patients with sustained AF [17]. Nevertheless, in our study the ERP measurements at different sites where not different between groups.…”
Section: Atrial Refractory Periodscontrasting
confidence: 63%
“…Shortening of the atrial ERP has been reported as one of the main underlying electrophysiological changes in patients with sustained AF [17]. Nevertheless, in our study the ERP measurements at different sites where not different between groups.…”
Section: Atrial Refractory Periodscontrasting
confidence: 63%
“…The physiological consequences of relatively brief periods (up to several hours) of atrial tachycardia, believed to be functional, can be prevented by several drugs, including L-type Ca 2ϩ -channel blockers, renin-angiotensin system antagonists, and Na ϩ ,H ϩ -exchange inhibitors. [17][18][19][20] Longer-term consequences, caused by changed gene expression, are not suppressed by any of these compounds. 12,14,21 The only agent that has been found to prevent ERP changes and AF promotion by longer-term atrial tachycardia is mibefradil, 13,14 which is no longer available.…”
Section: Comparison With Previous Studies Of Drug Effects On Atrial Tmentioning
confidence: 99%
“…Most studies about electrical atrial remodeling in humans have assessed subjects with and without overt cardiovascular disease [23][24][25]27 . Although micro structural atrial changes have been observed in lone AF 29 , gross and ultra-structural anatomic changes due to underlying cardiac disease, such as fibrosis, may persist indefinitely, despite the restoration to sinus rhythm and may be responsible for persistent electrophysiological abnormalities.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, a remarkable vulnerability to recurrence during post-cardioversion period has been observed while reverse remodeling is yet incomplete 23 . However, the necessary time to completely restore atrial electrophysiological properties, especially the conduction velocity, is yet to be defined.The methods employed for electrophysiological analysis are usually invasive [23][24][25]27 and make consecutive analysis of the same subject difficult, generating limitations to determine the moment of complete reversal remodeling. Furthermore, little is known about the effects of antiarrhythmic drugs on the remodeling process, especially amiodarone, frequently used in order to facilitate cardioversion and maintain sinus rhythm 28 .…”
mentioning
confidence: 99%